Annual Total Long Term Liabilities
$28.10 B
-$2.63 B-8.55%
31 December 2023
Summary:
Gilead Sciences annual total long term liabilities is currently $28.10 billion, with the most recent change of -$2.63 billion (-8.55%) on 31 December 2023. During the last 3 years, it has fallen by -$7.18 billion (-20.36%). GILD annual total long term liabilities is now -27.57% below its all-time high of $38.79 billion, reached on 31 December 2020.GILD Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$24.41 B
-$191.00 M-0.78%
30 September 2024
Summary:
Gilead Sciences quarterly total long term liabilities is currently $24.41 billion, with the most recent change of -$191.00 million (-0.78%) on 30 September 2024. Over the past year, it has dropped by -$3.69 billion (-13.12%). GILD quarterly long term liabilities is now -37.12% below its all-time high of $38.82 billion, reached on 31 March 2021.GILD Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -13.1% |
| 3 y3 years | -20.4% | -30.8% |
| 5 y5 years | -3.8% | -16.4% |
GILD Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.4% | at low | -30.8% | at low |
| 5 y | 5 years | -27.6% | at low | -37.1% | at low |
| alltime | all time | -27.6% | >+9999.0% | -37.1% | >+9999.0% |
Gilead Sciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $24.41 B(-0.8%) |
| June 2024 | - | $24.60 B(-4.7%) |
| Mar 2024 | - | $25.82 B(-8.1%) |
| Dec 2023 | $28.10 B(-8.6%) | $28.10 B(-0.3%) |
| Sept 2023 | - | $28.19 B(+3.3%) |
| June 2023 | - | $27.28 B(-10.3%) |
| Mar 2023 | - | $30.41 B(-1.0%) |
| Dec 2022 | $30.72 B(-12.9%) | $30.72 B(-1.1%) |
| Sept 2022 | - | $31.08 B(-7.1%) |
| June 2022 | - | $33.44 B(-3.4%) |
| Mar 2022 | - | $34.61 B(-1.9%) |
| Dec 2021 | $35.28 B(-9.1%) | $35.28 B(-0.3%) |
| Sept 2021 | - | $35.38 B(-7.0%) |
| June 2021 | - | $38.06 B(-2.0%) |
| Mar 2021 | - | $38.82 B(+0.1%) |
| Dec 2020 | $38.79 B(+32.8%) | $38.79 B(+14.4%) |
| Sept 2020 | - | $33.90 B(+24.5%) |
| June 2020 | - | $27.23 B(-5.1%) |
| Mar 2020 | - | $28.68 B(-1.8%) |
| Dec 2019 | $29.22 B(-7.4%) | $29.22 B(+1.3%) |
| Sept 2019 | - | $28.84 B(-8.4%) |
| June 2019 | - | $31.50 B(+0.5%) |
| Mar 2019 | - | $31.35 B(-0.6%) |
| Dec 2018 | $31.54 B(-17.3%) | $31.54 B(+1.1%) |
| Sept 2018 | - | $31.18 B(-4.7%) |
| June 2018 | - | $32.71 B(-4.0%) |
| Mar 2018 | - | $34.06 B(-10.7%) |
| Dec 2017 | $38.15 B(+34.3%) | $38.15 B(+28.0%) |
| Sept 2017 | - | $29.81 B(+3.9%) |
| June 2017 | - | $28.68 B(+0.6%) |
| Mar 2017 | - | $28.50 B(+0.4%) |
| Dec 2016 | $28.40 B(+25.0%) | $28.40 B(+0.8%) |
| Sept 2016 | - | $28.18 B(+20.3%) |
| June 2016 | - | $23.42 B(+2.6%) |
| Mar 2016 | - | $22.84 B(+0.5%) |
| Dec 2015 | $22.71 B(+73.6%) | $22.71 B(-2.7%) |
| Sept 2015 | - | $23.33 B(+71.5%) |
| June 2015 | - | $13.61 B(+2.3%) |
| Mar 2015 | - | $13.30 B(+1.7%) |
| Dec 2014 | $13.08 B(+195.6%) | $13.08 B(+46.6%) |
| Sept 2014 | - | $8.93 B(+4.4%) |
| June 2014 | - | $8.55 B(+1.0%) |
| Mar 2014 | - | $8.46 B(+91.1%) |
| Dec 2013 | $4.43 B(-40.6%) | $4.43 B(-30.6%) |
| Sept 2013 | - | $6.38 B(+0.6%) |
| June 2013 | - | $6.34 B(-15.7%) |
| Mar 2013 | - | $7.53 B(+0.9%) |
| Dec 2012 | $7.46 B(-5.8%) | $7.46 B(+0.6%) |
| Sept 2012 | - | $7.41 B(-0.3%) |
| June 2012 | - | $7.43 B(-11.5%) |
| Mar 2012 | - | $8.40 B(+6.0%) |
| Dec 2011 | $7.92 B(+163.5%) | $7.92 B(+89.4%) |
| Sept 2011 | - | $4.18 B(+0.2%) |
| June 2011 | - | $4.17 B(+3.2%) |
| Mar 2011 | - | $4.04 B(+34.5%) |
| Dec 2010 | $3.01 B(+127.4%) | $3.01 B(+0.6%) |
| Sept 2010 | - | $2.99 B(+332.2%) |
| June 2010 | - | $690.99 M(-47.1%) |
| Mar 2010 | - | $1.31 B(-1.2%) |
| Dec 2009 | $1.32 B(+5.7%) | $1.32 B(+2.0%) |
| Sept 2009 | - | $1.30 B(+0.0%) |
| June 2009 | - | $1.30 B(+4.4%) |
| Mar 2009 | - | $1.24 B(-0.8%) |
| Dec 2008 | $1.25 B | $1.25 B(-12.0%) |
| Sept 2008 | - | $1.42 B(+608.0%) |
| June 2008 | - | $200.76 M(-86.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $1.50 B(+0.2%) |
| Dec 2007 | $1.50 B(+3.1%) | $1.50 B(+1.0%) |
| Sept 2007 | - | $1.48 B(+0.6%) |
| June 2007 | - | $1.47 B(+0.6%) |
| Mar 2007 | - | $1.46 B(+0.8%) |
| Dec 2006 | $1.45 B(+431.5%) | $1.45 B(+2.4%) |
| Sept 2006 | - | $1.42 B(-3.8%) |
| June 2006 | - | $1.47 B(+581.8%) |
| Mar 2006 | - | $216.17 M(-20.9%) |
| Dec 2005 | $273.38 M(+764.1%) | $273.38 M(+705.1%) |
| Sept 2005 | - | $33.95 M(-2.7%) |
| June 2005 | - | $34.89 M(-2.5%) |
| Mar 2005 | - | $35.80 M(+13.1%) |
| Dec 2004 | $31.64 M(-91.4%) | $31.64 M(-91.5%) |
| Sept 2004 | - | $372.88 M(+1.7%) |
| June 2004 | - | $366.48 M(-0.3%) |
| Mar 2004 | - | $367.64 M(+0.5%) |
| Dec 2003 | $365.85 M(-40.2%) | $365.85 M(-40.6%) |
| Sept 2003 | - | $616.41 M(+0.8%) |
| June 2003 | - | $611.27 M(-0.1%) |
| Mar 2003 | - | $611.58 M(-0.1%) |
| Dec 2002 | $611.95 M(+133.4%) | $611.95 M(+128.4%) |
| Sept 2002 | - | $267.92 M(+4.2%) |
| June 2002 | - | $257.24 M(-1.7%) |
| Mar 2002 | - | $261.71 M(-0.2%) |
| Dec 2001 | $262.23 M(-2.4%) | $262.23 M(-0.3%) |
| Sept 2001 | - | $263.05 M(-0.9%) |
| June 2001 | - | $265.56 M(-0.9%) |
| Mar 2001 | - | $268.00 M(-0.3%) |
| Dec 2000 | $268.74 M(+193.3%) | $268.74 M(+2826.5%) |
| Sept 2000 | - | $9.18 M(-89.8%) |
| June 2000 | - | $89.70 M(-1.0%) |
| Mar 2000 | - | $90.61 M(-1.1%) |
| Dec 1999 | $91.64 M(-5.3%) | $91.64 M(-1.0%) |
| Sept 1999 | - | $92.60 M(>+9900.0%) |
| June 1999 | - | $200.00 K(-50.0%) |
| Mar 1999 | - | $400.00 K(-99.6%) |
| Dec 1998 | $96.80 M(+6814.3%) | $96.80 M(>+9900.0%) |
| Sept 1998 | - | $700.00 K(-22.2%) |
| June 1998 | - | $900.00 K(-18.2%) |
| Mar 1998 | - | $1.10 M(-21.4%) |
| Dec 1997 | $1.40 M(-51.7%) | $1.40 M(-12.5%) |
| Sept 1997 | - | $1.60 M(-15.8%) |
| June 1997 | - | $1.90 M(-13.6%) |
| Mar 1997 | - | $2.20 M(-24.1%) |
| Dec 1996 | $2.90 M(-17.1%) | $2.90 M(+107.1%) |
| Sept 1996 | - | $1.40 M(-33.3%) |
| June 1996 | - | $2.10 M(-22.2%) |
| Mar 1996 | - | $2.70 M(-35.7%) |
| Dec 1995 | $3.50 M(-35.2%) | - |
| Sept 1995 | - | $4.20 M(-10.6%) |
| June 1995 | - | $4.70 M(-13.0%) |
| Mar 1995 | - | $5.40 M(-12.9%) |
| Mar 1995 | $5.40 M(+116.0%) | - |
| Dec 1994 | - | $6.20 M(-4.6%) |
| Sept 1994 | - | $6.50 M(-5.8%) |
| June 1994 | - | $6.90 M(+176.0%) |
| Mar 1994 | $2.50 M(+127.3%) | $2.50 M(-7.4%) |
| Dec 1993 | - | $2.70 M(+35.0%) |
| Sept 1993 | - | $2.00 M(+42.9%) |
| June 1993 | - | $1.40 M(+27.3%) |
| Mar 1993 | $1.10 M(+57.1%) | $1.10 M(0.0%) |
| Dec 1992 | - | $1.10 M(+10.0%) |
| Sept 1992 | - | $1.00 M(+25.0%) |
| June 1992 | - | $800.00 K(+14.3%) |
| Mar 1992 | $700.00 K(+40.0%) | $700.00 K(+40.0%) |
| Mar 1991 | $500.00 K | $500.00 K |
FAQ
- What is Gilead Sciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Gilead Sciences?
- What is Gilead Sciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Gilead Sciences?
- What is Gilead Sciences quarterly long term liabilities year-on-year change?
What is Gilead Sciences annual total long term liabilities?
The current annual total long term liabilities of GILD is $28.10 B
What is the all time high annual total long term liabilities for Gilead Sciences?
Gilead Sciences all-time high annual total long term liabilities is $38.79 B
What is Gilead Sciences quarterly total long term liabilities?
The current quarterly long term liabilities of GILD is $24.41 B
What is the all time high quarterly long term liabilities for Gilead Sciences?
Gilead Sciences all-time high quarterly total long term liabilities is $38.82 B
What is Gilead Sciences quarterly long term liabilities year-on-year change?
Over the past year, GILD quarterly total long term liabilities has changed by -$3.69 B (-13.12%)